Multivariate survival analysis using the raw continuous value of total cellular or nuclear MSI2 percentage positivity
| Covariate . | Coefficient . | SE . | P . | Exp(b) . | 95% CI of Exp(b) . |
|---|---|---|---|---|---|
| Total cellular | |||||
| Age | 0.01642 | 0.009771 | .0928 | 1.0166 | 0.9974-1.0361 |
| FAB subtype | −0.04818 | 0.1002 | .6307 | 0.953 | 0.7838-1.1586 |
| Cytogenetic subtype | 0.4877 | 0.2676 | .0684 | 1.6285 | 0.9665-2.7441 |
| WBC | 0.001539 | 0.002165 | .4772 | 1.0015 | 0.9973-1.0058 |
| Percentage positive for MSI2 | 0.01565 | 0.008911 | .0791 | 1.0158 | 0.9983-1.0336 |
| Nuclear | |||||
| Age | 0.01905 | 0.01008 | .0588 | 1.0192 | 0.9994-1.0395 |
| FAB subtype | −0.03617 | 0.1006 | .7192 | 0.9645 | 0.7927-1.1735 |
| Cytogenetic subtype | 0.4246 | 0.2667 | .1114 | 1.5289 | 0.9089-2.5719 |
| WBC | 0.001116 | 0.002155 | .6047 | 1.0011 | 0.9969-1.0053 |
| Percentage positive for MSI2 | 0.02683 | 0.01367 | .0496 | 1.0272 | 1.0002-1.0549 |
| Covariate . | Coefficient . | SE . | P . | Exp(b) . | 95% CI of Exp(b) . |
|---|---|---|---|---|---|
| Total cellular | |||||
| Age | 0.01642 | 0.009771 | .0928 | 1.0166 | 0.9974-1.0361 |
| FAB subtype | −0.04818 | 0.1002 | .6307 | 0.953 | 0.7838-1.1586 |
| Cytogenetic subtype | 0.4877 | 0.2676 | .0684 | 1.6285 | 0.9665-2.7441 |
| WBC | 0.001539 | 0.002165 | .4772 | 1.0015 | 0.9973-1.0058 |
| Percentage positive for MSI2 | 0.01565 | 0.008911 | .0791 | 1.0158 | 0.9983-1.0336 |
| Nuclear | |||||
| Age | 0.01905 | 0.01008 | .0588 | 1.0192 | 0.9994-1.0395 |
| FAB subtype | −0.03617 | 0.1006 | .7192 | 0.9645 | 0.7927-1.1735 |
| Cytogenetic subtype | 0.4246 | 0.2667 | .1114 | 1.5289 | 0.9089-2.5719 |
| WBC | 0.001116 | 0.002155 | .6047 | 1.0011 | 0.9969-1.0053 |
| Percentage positive for MSI2 | 0.02683 | 0.01367 | .0496 | 1.0272 | 1.0002-1.0549 |
Covariates used: age at diagnosis, FAB subtype, cytogenetic subtype, and WBC at diagnosis.